BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 32564869)

  • 21. Efficacy and toxicity of doxorubicin and cyclophosphamide used in the treatment of selected malignant tumors in 23 cats.
    Mauldin GN; Matus RE; Patnaik AK; Bond BR; Mooney SC
    J Vet Intern Med; 1988; 2(2):60-5. PubMed ID: 3221358
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Incidence of sterile hemorrhagic cystitis in tumor-bearing dogs concurrently treated with oral metronomic cyclophosphamide chemotherapy and furosemide: 55 cases (2009-2015).
    Chan CM; Frimberger AE; Moore AS
    J Am Vet Med Assoc; 2016 Dec; 249(12):1408-1414. PubMed ID: 27901449
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Combination docetaxel/cyclophosphamide in patients with advanced solid tumors.
    Valero V
    Oncology (Williston Park); 1997 Aug; 11(8 Suppl 8):34-6. PubMed ID: 9364540
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Low dose meloxicam is safe and tolerable when combined with toceranib phosphate in cancer-bearing cats.
    Keepman SJ; Pellin MA
    J Feline Med Surg; 2022 Dec; 24(12):1187-1194. PubMed ID: 34923878
    [TBL] [Abstract][Full Text] [Related]  

  • 25. An EORTC phase I study of epirubicin in combination with fixed doses of cyclophosphamide and infusional 5-fu (CEF-infu) as primary treatment of large operable or locally advanced/inflammatory breast cancer.
    Bonnefoi H; Biganzoli L; Cufer T; Mauriac L; Hamilton A; Schaefer P; Piccart M
    Breast Cancer Res Treat; 2001 Nov; 70(1):55-63. PubMed ID: 11768362
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Phase I/II Trial of Combined Pegylated Liposomal Doxorubicin and Cyclophosphamide in Metastatic Breast Cancer.
    Chang AE; Wu QV; Jenkins IC; Specht JM; Gadi VK; Gralow JR; Salazar LG; Kurland BF; Linden HM
    Clin Breast Cancer; 2018 Feb; 18(1):e143-e149. PubMed ID: 29174203
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Pilot study of oral metformin in cancer-bearing cats.
    Wypij JM
    Vet Comp Oncol; 2017 Jun; 15(2):345-354. PubMed ID: 26490666
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Phase I and pharmacokinetic evaluation of the combination of orally administered docetaxel and cyclosporin A in tumor-bearing cats.
    McEntee MC; Rassnick KM; Bailey DB; Balkman CE; Flanagan JL; Beaulieu BB; Zgola MM; Lewis LD; Page RL
    J Vet Intern Med; 2006; 20(6):1370-5. PubMed ID: 17186852
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Dose-escalated cyclophosphamide, doxorubicin, vincristine, prednisone, and etoposide (CHOPE) chemotherapy for patients with diffuse lymphoma: Cancer and Leukemia Group B studies 8852 and 8854.
    Bartlett NL; Petroni GR; Parker BA; Wagner ND; Gockerman JP; Omura GA; Canellos GP; Robert M; Johnson JL; Peterson BA
    Cancer; 2001 Jul; 92(2):207-17. PubMed ID: 11466671
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Phase I lead-in and subsequent randomized trial assessing safety and modulation of regulatory T cell numbers following a maximally tolerated dose doxorubicin and metronomic dose cyclophosphamide combination chemotherapy protocol in tumour-bearing dogs.
    Rasmussen RM; Kurzman ID; Biller BJ; Guth A; Vail DM
    Vet Comp Oncol; 2017 Jun; 15(2):421-430. PubMed ID: 26522053
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Pharmacokinetics of cyclophosphamide and 4-hydroxycyclophosphamide in cats after oral, intravenous, and intraperitoneal administration of cyclophosphamide.
    Stroda KA; Murphy JD; Hansen RJ; Brownlee L; Atencio EA; Gustafson DL; Lana SE
    Am J Vet Res; 2017 Jul; 78(7):862-866. PubMed ID: 28650232
    [TBL] [Abstract][Full Text] [Related]  

  • 32. An open-label, dose-escalating phase I study of elsamitrucin (SPI 28090) in treatment of malignant solid tumors in dogs.
    Fiocchi SC; Selting KA; Rosenberg MP; Kolli P; Lenaz G; Henry C
    J Vet Intern Med; 2011; 25(4):897-902. PubMed ID: 21736623
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Vinorelbine and low-dose cyclophosphamide in the treatment of pediatric sarcomas: pilot study for the upcoming European Rhabdomyosarcoma Protocol.
    Casanova M; Ferrari A; Bisogno G; Merks JH; De Salvo GL; Meazza C; Tettoni K; Provenzi M; Mazzarino I; Carli M
    Cancer; 2004 Oct; 101(7):1664-71. PubMed ID: 15378498
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Phase I study of oral cyclophosphamide and oral topotecan for children with recurrent or refractory solid tumors.
    Bowers DC; Aquino VM; Leavey PJ; Bash RO; Journeycake JM; Tomlinson G; Mulne AF; Haynes HJ; Winick NJ
    Pediatr Blood Cancer; 2004 Jan; 42(1):93-8. PubMed ID: 14752800
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A phase I study of pemetrexed (ALIMTA) and cyclophosphamide in patients with locally advanced or metastatic breast cancer.
    Dittrich C; Petruzelka L; Vodvarka P; Gneist M; Janku F; Kysela T; Melemed A; Latz J; Simms L; Krejcy K
    Clin Cancer Res; 2006 Dec; 12(23):7071-8. PubMed ID: 17145830
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Paclitaxel, epirubicin and cyclophosphamide combination in first-line treatment of metastatic breast cancer: a dose escalation study.
    Bonneterre J; Tubiana-Hulin M; Catimel G
    Oncology; 2004; 66(3):185-91. PubMed ID: 15218308
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Phase I study of combination therapy with weekly paclitaxel and cyclophosphamide for advanced or recurrent breast cancer.
    Masuda N; Nakayama T; Yamamura J; Kamigaki S; Taguchi T; Hatta M; Sakamoto J
    Cancer Chemother Pharmacol; 2010 May; 66(1):89-94. PubMed ID: 19768460
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Multiple cycles of high-dose doxorubicin and cyclophosphamide with G-CSF mobilized peripheral blood progenitor cell support in patients with metastatic breast cancer.
    Honkoop AH; van der Wall E; Feller N; Schuurhuis GJ; van der Vijgh WJ; Boven E; van Groeningen CJ; Giaccone G; Hoekman K; Vermorken JB; Wagstaff J; Pinedo HM
    Ann Oncol; 1997 Oct; 8(10):957-62. PubMed ID: 9402167
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Chemotherapy of lymphoma in 75 cats.
    Jeglum KA; Whereat A; Young K
    J Am Vet Med Assoc; 1987 Jan; 190(2):174-8. PubMed ID: 3818430
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Retrospective evaluation of toceranib phosphate (Palladia®) toxicity in cats.
    Merrick CH; Pierro J; Schleis SE; Sones EA; Wright ZM; Regan RC; Siedlecki CT; Bergman PJ
    Vet Comp Oncol; 2017 Sep; 15(3):710-717. PubMed ID: 27041701
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.